Biofil Chemicals & Pharmaceuticals profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 13.8% | 13.8% | 3.0% | 4.0% | 3.3% | ||
| 5.9% | 5.9% | 1.1% | 1.8% | 2.2% | ||
| 1.8% | 1.8% | 2.5% | 2.3% | 4.2% | ||
| 1.2% | 1.2% | 1.9% | 1.8% | 2.9% | ||
Margins | ||||||
| 2.3% | 2.3% | 2.5% | 2.0% | 3.9% | ||
| 1.3% | 1.3% | 1.4% | 1.0% | 2.5% | ||
| — | 1.8% | −0.8% | −3.2% | — | ||
| 2.4% | 12.1% | 2.2% | 2.2% | 2.6% | ||
| 1.4% | 9.8% | 1.7% | 1.8% | 1.9% | ||
| −2.8% | −2.8% | −6.1% | 5.9% | −0.4% | ||
Additional | ||||||
| 41.1% | 19.2% | 24.2% | 18.0% | 29.3% | ||
| 13.8% | 13.8% | 3.0% | 4.0% | 3.3% | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.